Abnormalities, Multiple: Clinical Trials

1 trial for Abnormalities, Multiple, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 enrolling by invitation. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Enrolling by invitation 1

Follow Abnormalities, Multiple: new trials by email Literature Review of Abnormalities, Multiple trials Research Report on Abnormalities, Multiple

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Atorvastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease
Atorvastatin 20 Mg Oral Tablet, Sodium Bicarbonate 600 Mg Oral Tablet - Autosomal Dominant Polycystic Kidney Disease, Chronic Kidney Diseases
Phase 2Enrolling by invitationTaipei Medical University Shuang Ho Hospital302023-05-012023-05-23

Narrower conditions

Polycystic Kidney, Autosomal Dominant (1)  ·  Renal Insufficiency, Chronic (1)

Broader conditions

Chronic Disease (1)  ·  Ciliopathies (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Disease Attributes (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genetic Diseases, Inborn (1)  ·  Kidney Diseases (1)  ·  Kidney Diseases, Cystic (1)  ·  Male Urogenital Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Polycystic Kidney Diseases (1)

Interventions

Atorvastatin (1)  ·  Sodium Bicarbonate (1)  ·  Tablets (1)

Sponsors

Taipei Medical University Shuang Ho Hospital (1)

Countries

Taiwan (1)

Results publications

PMID 39356039